Literature DB >> 20433786

Candida glabrata: an emergent opportunist in vulvovaginitis.

Rafael Buitrón García-Figueroa1, Javier Araiza-Santibáñez, Erich Basurto-Kuba, Alexandro Bonifaz-Trujillo.   

Abstract

BACKGROUND: Candida genus has various species. The incidence of C. glabrata has presented itself with more frequency over the past years with clinical importance.
METHODS: A case study was made to determine the frequency of C. glabrata in 468 patients who presented clinical symptomatology for vulvovaginal candidiasis and the in vitro response for fluconazole using two methods: diffusion in agar plates and microdilution in liquid medium [NCLSI (NCCLS) method].
RESULTS: The frequency for this specie was 12.6%, almost double the frequency observed 10 years ago. The resistance of C. glabrata to fluconazole treatment was confirmed in this study, representing 68.2% resistance in all strains on test plates and 51.2% on NCLSI method with a MIC of 16 microg/ml.
CONCLUSIONS: The frequency of Candida glabrata has increased over the past years. It presents resistance to usual treatments, which promotes the persistence and recurrence of genital and systemic infections.

Entities:  

Mesh:

Year:  2009        PMID: 20433786

Source DB:  PubMed          Journal:  Cir Cir        ISSN: 0009-7411            Impact factor:   0.361


  5 in total

1.  Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasis.

Authors:  E P Garvey; W J Hoekstra; R J Schotzinger; J D Sobel; E A Lilly; P L Fidel
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

2.  Structural basis for promiscuity and specificity during Candida glabrata invasion of host epithelia.

Authors:  Manuel Maestre-Reyna; Rike Diderrich; Maik Stefan Veelders; Georg Eulenburg; Vitali Kalugin; Stefan Brückner; Petra Keller; Steffen Rupp; Hans-Ulrich Mösch; Lars-Oliver Essen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-03       Impact factor: 11.205

3.  Distribution and Drug Susceptibility of Candida spp. Associated With Female Genital Tract Infection, Chongqing, China.

Authors:  Xiaodong Luo; Xiaojing Dong; Zhi Pen
Journal:  Jundishapur J Microbiol       Date:  2015-09-08       Impact factor: 0.747

4.  Sorbic acid stress activates the Candida glabrata high osmolarity glycerol MAP kinase pathway.

Authors:  Zeljkica Jandric; Christa Gregori; Eva Klopf; Martin Radolf; Christoph Schüller
Journal:  Front Microbiol       Date:  2013-11-26       Impact factor: 5.640

5.  β-Glucan induces reactive oxygen species production in human neutrophils to improve the killing of Candida albicans and Candida glabrata isolates from vulvovaginal candidiasis.

Authors:  Patricia de Souza Bonfim-Mendonça; Bianca Altrão Ratti; Janine da Silva Ribeiro Godoy; Melyssa Negri; Nayara Cristina Alves de Lima; Adriana Fiorini; Elaine Hatanaka; Marcia Edilaine Lopes Consolaro; Sueli de Oliveira Silva; Terezinha Inez Estivalet Svidzinski
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.